Skip to search formSkip to main contentSkip to account menu

CIGB-300

Known as: CK2-targeting Synthetic Peptide CIGB-300 
A synthetic peptide targeting the substrates of casein kinase 2 (CK2), with potential antineoplastic activity. Upon administration and nucleolar… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • C. Ra
  • 2019
  • Corpus ID: 201979384
Mass spectrometry alone or in combination with liquid chromatography has become the analytical tool by choice to achieve… 
2018
2018
Background: CIGB-300 is an anti-CK2 peptide previously tested by intralesional injections. Here, we explored tolerability, drug… 
2017
2017
El CIGB le ha apostado al empleo de los peptidos sinteticos como agentes terapeuticos para el tratamiento de enfermedades como el… 
2016
2016
Introduccion: el CIGB-300 es un peptido sintetico capaz de producir apoptosis en celulas tumorales. Objetivos: explorar la… 
2015
2015
CIGB-300 is a synthetic peptide that inhibits the phosphorylation mediated by enzyme casein kinase 2 (CK2) and has a marked… 
2014
2014
CIGB-300 is a synthetic peptide that inhibits the phosphorylation mediated by enzyme casein kinase 2 (CK2) and has a marked… 
2012
2012
El CIGB-300 es un peptido sintetico seleccionado por su capacidad de inhibir la fosforilacion catalizada por la enzima CK2 a…